Opella Healthcare Belgium NV/SA
0753.785.218 · rovalta.com · 28/09/2026
ACTIVE
Opella Healthcare Belgium NV/SA
Financial year 2025 · Closed on 31/12/2025
Net result1,1 M €-52,8 %over 1 year
Revenue36,2 M €-5,5 %over 1 year
Equity20,7 M €-3,8 %over 1 year
Workforce39,1 ETP-14,1 %over 1 year
Overview
Identity
Source · BCE/KBOOpella Healthcare Belgium NV/SA is a Public limited company incorporated in 2020. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Machelen (Brab.). It employs on average 39,1 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0753.785.218
- Incorporation
- 08/09/2020
- Legal form
- Public limited company
- Registered office
- Leonardo da Vincilaan 19
1831 Machelen (Brab.) · FlandreSee on map - Contributed capital
- 18 693 565,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 39,1 ETP
Activities (NACE)
21209Manufacture of pharmaceutical preparations· main21209Manufacture of pharmaceutical preparations46460Wholesale of pharmaceutical goods46460Wholesale of pharmaceutical goods46150Agents involved in the sale of furniture, household goods, hardware and ironmongery46150Agents involved in the sale of furniture, household goods, hardware and ironmongery+2
Joint committees (1)
- 20000
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Financials
Source · NBB, 7 filingsTrend over 5 financial years
| 2025 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 36,2 M € | -5.5% | 38,3 M € | +2.7% | 37,3 M € | +472% | 6,5 M € | – | |
| EBITDA | 989,1 k € | -82.6% | 5,7 M € | +146% | 2,3 M € | +291% | 592,6 k € | +8893% | -6,7 k € |
| Operating result | 598 k € | -79.4% | 2,9 M € | +393% | 589,1 k € | +8722% | -6,8 k € | -1.4% | -6,7 k € |
| Net result | 1,1 M € | -52.8% | 2,4 M € | +510% | 386,5 k € | +3380% | -11,8 k € | -74.8% | -6,7 k € |
| Balance sheet | |||||||||
| Equity | 20,7 M € | -3.8% | 21,5 M € | +12.3% | 19,1 M € | +2.1% | 18,7 M € | +34116% | 54,8 k € |
| Total assets | 32,3 M € | -2.9% | 33,3 M € | +7.6% | 30,9 M € | +21.6% | 25,4 M € | +41267% | 61,5 k € |
| Cash | 2,2 k € | -97.3% | 82,5 k € | +34.8% | 61,2 k € | -82.8% | 355 k € | – | |
| Debts | 11,6 M € | +4.2% | 11,2 M € | -5.5% | 11,8 M € | +76.2% | 6,7 M € | +99369% | 6,7 k € |
| Other | |||||||||
| Workforce | 39,1 ETP | -14.1% | 45,5 ETP | +3.9% | 43,8 ETP | +0.7% | 43,5 ETP | – | |
Valuation
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20252 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Christian BETANCOURT | Director13/12/2023 → 08/06/2029 | ||
Gilles LAHURE | Director01/04/2023 → 08/06/2029 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Sophie De Soignies | Director01/12/2021 → 08/06/2029 | ||
Fabio CAPPUCCIO | Managing director01/04/2021 → 09/06/2023 | ||
Peter Oldenziel | Director08/09/2020 → 12/06/2026 |
Other companies at this address
Leonardo da Vincilaan 19 1831 Machelen (Brab.)| Company | CBE no. |
|---|---|
ABAX Belgium● Active | 0480.062.304 |
ARCADIUS● Active | 0460.076.344 |
Arquebus Solutions Europe● Active | 0759.406.763 |
AURALES● Bankrupt | 0424.296.014 |
BRUSSELS EAST PROPERTY PARTNERS● Active | 0799.771.136 |
CGI Belgium● Active | 0441.137.687 |
| 0793.224.131 | |
| 0418.159.080 | |
Dental Innovation Investment A● Active | 0713.471.028 |
DENTAL INNOVATIONS● Active | 0864.176.463 |
DHSVDE● Bankrupt | 0720.521.542 |
FAIRTUAL TECHNOLOGIES● Bankrupt | 0899.916.411 |
FIBIZ PARTNERS● Active | 0888.368.956 |
GEMA Benelux● Active | 0639.961.755 |
Green Dot Consulting● Active | 0749.646.088 |
IMMOBILIERE VAN EYCK● Active | 0738.991.233 |
KS Consulting Belgium● Active | 1024.216.664 |
LV INVESTMENT● Active | 0859.984.578 |
MAS BNL● Active | 0471.544.912 |
MC-SQUARE Belgium● Active | 0468.341.041 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 08/09/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 4 months |
| Filing date | 02/07/2026 | 13/11/2025 | 18/10/2024 | 05/04/2024 | 02/12/2022 | 14/07/2021 |
| General meeting | 29/06/2026 | 17/10/2025 | 24/09/2024 | 21/03/2024 | 28/10/2022 | 14/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 29/06/2026 | 02/07/2026 | Dutch | |
| Full model | 31/12/2024 | 17/10/2025 | 13/11/2025 | Dutch | |
| Full modelCorrection | 31/12/2023 | 24/09/2024 | 18/10/2024 | Dutch | |
| Full model | 31/12/2023 | 14/06/2024 | 06/08/2024 | Dutch | |
| Full model | 31/12/2022 | 21/03/2024 | 05/04/2024 | Dutch | |
| Full model | 31/12/2021 | 28/10/2022 | 02/12/2022 | Dutch | |
| Full model | 31/12/2020 | 14/06/2021 | 14/07/2021 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Christian BETANCOURT | Director13/12/2023 → 08/06/2029 | ||
Gilles LAHURE | Director01/04/2023 → 08/06/2029 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Sophie De Soignies | Director01/12/2021 → 08/06/2029 | ||
Fabio CAPPUCCIO | Managing director01/04/2021 → 09/06/2023 | ||
Peter Oldenziel | Director08/09/2020 → 12/06/2026 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates07/11/2024ONTSLAGEN - BENOEMINGEN
- Capital / shares26/07/2024KAPITAAL - AANDELEN
- Mandates29/03/2024ONTSLAGEN - BENOEMINGEN
- Other18/12/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DOEL
- Mandates04/05/2023ONTSLAGEN - BENOEMINGEN
- Capital / shares20/01/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates06/12/2021ONTSLAGEN - BENOEMINGEN
- Capital / shares12/10/2021KAPITAAL - AANDELEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings5 filings
Mandates
Christian BETANCOURT
Gilles LAHURE
Sophie De Soignies
Fabio CAPPUCCIO
Peter OLDENZIEL
2020202120222023202420252026202720282029
Opella Healthcare Belgium NV/SA
Leonardo da Vincilaan 19, 1831 Diegem
Director
Director
Director
Managing director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Leonardo da Vincilaan 19, 1831 DiegemCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00250711 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Opella Healthcare Belgium NV/SACurrent | accounts 2020 → 2025 | Accounts 2025 · 2026-00250711 |
Events
- 2025Annual accounts 20251,1 M €↓
- 2023Annual accounts 20232,4 M €↑
- 2022Annual accounts 2022386,5 k €↑
- 2021Annual accounts 2021-11,8 k €↓
- 2020Annual accounts 2020-6,7 k €
- 08/09/2020IncorporationPublic limited company